Skip to main content

Table 2 Patients, treatment data, visual acuities, visual fields and follow-up

From: Tuberculosis-related serpiginous choroiditis: aggressive therapy with dual concomitant combination of multiple anti-tubercular and multiple immunosuppressive agents is needed to halt the progression of the disease

Patients

Gender/Age

Eye OD/OS

Time to 1st visit

Duration of Anti-TB ttt

Total duration of treatment

Recurrence free, without treatment

VA 1

VA 2

VF 1 (MD)

VF 2 (MD)

Patient 1

M/38

OD

4 months

15 months

36 months

36 months

1.0

1.0

9

1.3

OS

1.0

1.0

10

1.5

Patient 2

W/42

OD

8 months

15 months

24 months

9 years

1.0

1.0

2.8

2.1

OS

0.9

1.0

5.3

5.0

Patient 3

W/32

OD

66 months

12 months

16 months

2 months (Lost to F-UP)

1.0

1.0

−1.4

−1.3

OS

10

1.0

−1.1

−1.6

Patient 4

M/44

OD

12 years (132 m)

24 months

Still under treatment (15 years)

Still under treatment

0.1

0.16

25.3

15.6

OS

0.05

0.16

19.4

16.6

  1. Ttt treatment, VA visual acuity, VF visual field, MD mean deviation, 1 = at presentation, 2 = last visit